[CT evolution of nasal steroid management of chronic rhinosinusitis]

Luo Zhang1, Cheng-shuo Wang, De-min Han

  • 1Department of Otorhinolaryngology Head and Neck Surgery, Affiliated Beijing Tongren Hospital of Capital University of Medical Sciences, Beijing Institute of Otorhinolaryngology, Beijing 100730, China. luozhang@trhos.com

Insights

Topical steroid treatment effectively reduced symptoms and improved imaging in nonpolypoid chronic sinusitis patients. Most patients showed significant improvement, reducing the need for surgery.

Area of Science:

  • Otolaryngology
  • Pharmacology

Background:

  • Nonpolypoid chronic sinusitis presents a therapeutic challenge.
  • Topical steroid efficacy in this specific subtype requires further investigation.

Purpose of the Study:

  • To evaluate the effectiveness of topical steroid treatment for nonpolypoid chronic sinusitis in both adult and pediatric populations.

Main Methods:

  • Two cohorts (11 pediatric, 13 adult) with nonpolypoid chronic sinusitis were treated with nasal budesonide.
  • Treatment duration averaged 7-7.5 weeks with daily dosages of 128-256 microg/d.
  • Lund scores and patient-reported symptoms were assessed pre- and post-treatment.

Main Results:

  • Significant reductions in Lund scores were observed in both adult (P < 0.01) and pediatric (P < 0.01) groups.
  • CT imaging showed a cure rate of 38% in adults and 73% in children.
  • Adult patient self-assessment correlated with initial symptom severity (r = 0.676, P < 0.05).

Conclusions:

  • Topical steroid therapy is highly effective for nonpolypoid chronic sinusitis.
  • The majority of patients experienced significant symptom relief and improved sinus conditions.
  • Surgical intervention was infrequently required following this treatment regimen.
Abstract

Related Concept Videos

Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Epistaxis01:30

Epistaxis

Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation